Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Methylphenidate Primed iTBS for Apathy in Neurocognitive Disorders

NCT07279740 is registered in ClinicalTrials.gov with Sunnybrook Health Sciences Centre as lead sponsor.

NCT NCT07279740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07279740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Methylphenidate Primed iTBS for Apathy in Neurocognitive Disorders
Lead sponsor
Sunnybrook Health Sciences Centre
Phase
Phase 2
Overall status
Recruiting
Start date
January 31, 2026
Completion date
October 1, 2027
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer dementia, alzheimer dementia (ad), alzheimer disease, alzheimer s disease, apathy, apathy in dementia